|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0000981,
umls-concept:C0002349,
umls-concept:C0008976,
umls-concept:C0018681,
umls-concept:C0018837,
umls-concept:C0020740,
umls-concept:C0023981,
umls-concept:C0034656,
umls-concept:C0199176,
umls-concept:C0220825,
umls-concept:C0238617,
umls-concept:C1707455
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2010-9-13
|
|
pubmed:abstractText |
High altitude headache (HAH) is the most common neurological complaint at altitude and the defining component of acute mountain sickness (AMS). However, there is a paucity of literature concerning its prevention. Toward this end, we initiated a prospective, double-blind, randomized, placebo-controlled trial in the Nepal Himalaya designed to compare the effectiveness of ibuprofen and acetazolamide for the prevention of HAH.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1545-1534
|
|
pubmed:author |
pubmed-author:AllisonEricE,
pubmed-author:BasnyatBuddhaB,
pubmed-author:FisherRobert SRS,
pubmed-author:GertschJeffrey HJH,
pubmed-author:HanzelkaKeeliK,
pubmed-author:HazanAlbertoA,
pubmed-author:HolckPeter SPS,
pubmed-author:LipmanGrant SGS,
pubmed-author:MerrittAndrewA,
pubmed-author:MeyersZacharyZ,
pubmed-author:MulcahyAllisonA,
pubmed-author:OdegaardJustinJ,
pubmed-author:PookBenjaminB,
pubmed-author:SlomovicBrantB,
pubmed-author:ThompsonMarkM,
pubmed-author:WahlbergHenrikH,
pubmed-author:WeissEric AEA,
pubmed-author:WilshawVanessaV,
pubmed-author:ZafrenKenK
|
|
pubmed:copyrightInfo |
Copyright 2010 Wilderness Medical Society. Published by Elsevier Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
236-43
|
|
pubmed:meshHeading |
pubmed-meshheading:20832701-Acetazolamide,
pubmed-meshheading:20832701-Adolescent,
pubmed-meshheading:20832701-Adult,
pubmed-meshheading:20832701-Aged,
pubmed-meshheading:20832701-Altitude Sickness,
pubmed-meshheading:20832701-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:20832701-Double-Blind Method,
pubmed-meshheading:20832701-Female,
pubmed-meshheading:20832701-Headache,
pubmed-meshheading:20832701-Humans,
pubmed-meshheading:20832701-Ibuprofen,
pubmed-meshheading:20832701-Logistic Models,
pubmed-meshheading:20832701-Male,
pubmed-meshheading:20832701-Middle Aged,
pubmed-meshheading:20832701-Mountaineering,
pubmed-meshheading:20832701-Pain Measurement,
pubmed-meshheading:20832701-Placebos,
pubmed-meshheading:20832701-Young Adult
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Prospective, double-blind, randomized, placebo-controlled comparison of acetazolamide versus ibuprofen for prophylaxis against high altitude headache: the Headache Evaluation at Altitude Trial (HEAT).
|
|
pubmed:affiliation |
Department of Neurosciences, University of California-San Diego School of Medicine, San Diego, CA 92103-8465, USA. jgertsch@ucsd.edu
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
